These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23565456)

  • 1. Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset untreated, type 2 diabetes Indian subjects.
    Sanyal D; Ghosh S; Mukherjee P; Mukherjee S; Chowdhury S
    Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 2):S434-5. PubMed ID: 23565456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.
    Sanyal D; Mukherjee P; Raychaudhuri M; Ghosh S; Mukherjee S; Chowdhury S
    Indian J Endocrinol Metab; 2015; 19(5):597-601. PubMed ID: 26425466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NRFLD), in recently detected untreated, IGT and type 2 diabetes Indian subjects.
    Sanyal D; Mukhopadhyay P; Pandit K; Mukhopadhyay S; Chowdhury S
    J Indian Med Assoc; 2009 Nov; 107(11):755-8. PubMed ID: 20469778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay Between the American Diabetes Association's ABC Targets for Diabetes, Insulin Resistance Indices, and Dyslipidemia in Indian Type 2 Diabetes Patients.
    Tripathi P; Tiwari D; Kathrikolly T; Vyawahare A; Sharma B; Ganla M; K M; Vijayakumar V; Saboo B; Kadam NS
    Cureus; 2024 May; 16(5):e60268. PubMed ID: 38872654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
    Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
    Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical characteristics and its relationship with metabolic syndrome in elderly subjects with impaired glucose regulation].
    Zhang SH; Ren W; Li G; Li QF; Lu XE; Ma GC; Bao BN; Chen J; Ni YX; Zhang Z; Wang ZH; Wang JW; Wu J; Du J; Deng JR; Tang L; Huang WJ; Wu HJ; Zhang Y; Li H
    Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1957-61. PubMed ID: 14703430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome (MetS) in Chinese subjects gradually increased with impaired glucose homeostasis: a multicenter, clinical based, cross-sectional study.
    Xiang Y; Huang G; Zhou W; Che Z; Zhou P; Zhou Z
    BMC Public Health; 2012 Aug; 12():675. PubMed ID: 22905725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.
    Nagaretani H; Nakamura T; Funahashi T; Kotani K; Miyanaga M; Tokunaga K; Takahashi M; Nishizawa H; Kishida K; Kuriyama H; Hotta K; Yamashita S; Matsuzawa Y
    Diabetes Care; 2001 Dec; 24(12):2127-33. PubMed ID: 11723095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.
    Ferrara CM; Goldberg AP
    Diabetes Care; 2001 Feb; 24(2):245-9. PubMed ID: 11213873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
    Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
    Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.